Results 41 to 50 of about 101,157 (242)

Human immunodeficiency virus rebound after suppression to < 400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression [PDF]

, 2002
This study evaluated 1433 human immunodeficiency virus (HIV)-infected patients starting highly active antiretroviral therapy (HAART), 409 (28%) of whom had prior nucleoside experience and achieved an HIV load of
Bickel, M, Doerr, HW, Johnson, MA, Klauke, S, Lampe, F, Loveday, C, Miller, V, Phillips, AN, Royal Free Ctr HIV Med Goethe Univ, Sabin, CA, Staszewski, S, Youle, MS   +11 more
core   +1 more source

Update on highly active antiretroviral therapy: progress and strategies [PDF]

Biomedicine & Pharmacotherapy, 2000
HIV patients who have detectable viral loads (1,000-5,000 copies/mL) and/or evidence of immunologic dysfunction (CD4+ T-lymphocyte count < 500/mm3) should be treated with a potent combination antiretroviral regimen. Currently, this is to consist of two nucleoside reverse transcriptase inhibitors (NRTIs) with at least one protease inhibitor (PI), or a ...
Clumeck, Nathan, De Wit, Stéphane
openaire   +2 more sources

Hematological parameters abnormalities and associated factors in HIV-positive adults before and after highly active antiretroviral treatment in Goba Referral Hospital, southeast Ethiopia: A cross-sectional study

SAGE Open Medicine, 2021
Objectives: Hematological abnormalities of the major blood cell lines are frequently reported in patients with HIV-1 infection, in patients without antiretroviral therapy, and during the advanced stages of the disease.
Negesso Duguma, Girum Tesfaye Kiya, Wondimagegn Adissu Maleko, Lealem Gedefaw Bimerew   +3 more
doaj   +1 more source

Positive Outcomes of HAART at 24 Months in HIV-Infected Patients in Cambodia. [PDF]

, 2007
OBJECTIVES: African and Asian cohort studies have demonstrated the feasibility and efficacy of HAART in resource-poor settings. The long-term virological outcome and clinico-immunological criteria of success remain important questions.
Bartlett, Bartlett, Bourgeois, Calmy, Calmy, Carrieri, Carrieri, Coetzee, Colebunders, Colebunders, Dabis, Ferradini, Gill, Gonzalez de, Grabar, Ivers, Kumarasamy, Laurent, Laurent, Lawn, Lawn, Lawn, Le Moing, Ly, Madec, Marzolini, Orrell, Pasquier, Rouet, Rouzioux, Severe, Tassie, Van Heeswijk, Weidle, Wu, Zhou   +35 more
core   +2 more sources

Classical and alternative macrophages have impaired function during acute and chronic HIV-1 infection

Brazilian Journal of Infectious Diseases, 2017
Objectives: Three decades after HIV recognition and its association with AIDS development, many advances have emerged – especially related to prevention and treatment.
Leonardo J. Galvão-Lima, Milena S. Espíndola, Luana S. Soares, Fabiana A. Zambuzi, Maira Cacemiro, Caroline Fontanari, Valdes R. Bollela, Fabiani G. Frantz   +7 more
doaj   +1 more source

Outcomes of a remote, decentralized health center-based HIV/AIDS antiretroviral program in Zambia, 2003 to 2007 [PDF]

, 2009
A cross-sectional study of patients living with HIV/ AIDS treated during 2003 to 2007 in decentralized, rural health centers in Zambia was performed to measure virological outcomes after 12 months of antiretroviral therapy and identify factors associated
Elema, R, Mills, C, Yun, O, Lokuge, K, Ssonko, C, Nyirongo, N, Mtonga, V, Zulu, H, Tu, D, Verputten, M, O'Brien, D P   +10 more
core   +2 more sources

Long-term use of first-line highly active antiretroviral therapy is not associated with carotid artery stiffness in human immunodeficiency virus-positive patients

Brazilian Journal of Infectious Diseases, 2014
Objective: To evaluate whether or not highly active antiretroviral therapy is associated with carotid artery stiffness in human immunodeficiency virus-positive patients in Henan Province, China.
Haohui Zhu, Jianjun Yuan, Yisa Wang, Fan Gao, Xiao Wang, Changhua Wei, Jiyun Chen, Xiaohui Fan, Mei Zhang   +8 more
doaj   +1 more source

Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users. [PDF]

, 2012
Objectives  To identify factors influencing mortality in an HIV programme providing care to large numbers of injecting drug users (IDUs) and patients co-infected with hepatitis C (HCV).
ATC Collaboration, Bassetti, Benhamou, Bonnet, Braitstein, Celentano, Chander, Chen, Chun, Coetzee, Collett, Ding, Dore, Dou, Ferradini, Garten, Gebo, Grambsch, Gross, Kerr, Knowlton, Liu, Martinez, Mills, Mohsen, National Center for AIDS/STD Control and Prevention., Nelson, Pujades-Rodriguez, Rhodes, Smit, Tassie, Te, Wainberg, Werb, Wood, Wood, Wood, Zachariah, Zhang   +38 more
core   +2 more sources

Identification of serodiscordant couples, their clinical and laboratory characteristics, and vulnerabilities of HIV transmission risk in Northeastern Brazil in the era of pre-exposure prophylaxis (PrEP)

Revista Ciências em Saúde, 2020
Objectives: To evaluate the frequency of HIV serodiscordants couples and their seronegative partners who were candidates for pre-exposure prophylaxis (PrPE), and the knowledge about behavioural measures to reduce virus transmission. Methods: The research
Maíra Gomes Monteiro, Adriana Farrant Braz, Kledoaldo Lima, Heloísa Ramos Lacerda   +3 more
doaj   +1 more source

Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis [PDF]

, 2009
BACKGROUND: The retention of patients in antiretroviral therapy (ART) programmes is an important issue in resource-limited settings. Loss to follow up can be substantial, but it is unclear what the outcomes are in patients who are lost to programmes ...
Martin W. G. Brinkhof, Mar Pujades-Rodriguez, Matthias Egger, Sean Emery, M Egger, A Mocroft, FJ Palella Jr, P Braitstein, CT Yiannoutsos, MW Brinkhof, S Rosen, M Dahab, DW Krebs, M-W An, P Ive, RP Dalal, JK-L Yu, EH Geng, GP Bisson, M Maskew, M Hochgesang, M McGuire, A Billy, G Lurton, K Deribe, K Joshi, A Muwanga, L Ferradini, A Boulle, JS Stringer, JF Etard, M Forster, R Zachariah, AP Hardon, S Weiser, A Ammassari, A Ammassari, S Rueda, EJ Mills   +38 more
core   +4 more sources